The Clinical Medicine Department of the Reproductive Medicine Center of the Chongqing Health Center for Women and Children (Women and Children's Hospital of Chongqing Medical University), or CQHCWC, is the first reproductive center in the country to be approved by the former Ministry of Health – now the National Health Commission – to use human-assisted reproductive technology. It is one of the first assisted reproductive technology training bases in the country.

The department also includes the Chongqing Key Laboratory for Human Embryo Engineering, the Chongqing Reproductive Medicine Clinical Medical Research Center, and the Chongqing Assisted Reproduction Special Disease Clinical Diagnosis and Treatment Center.

In addition, the department was the first in West China to facilitate pregnancy through in vitro fertilization (IVF) and to utilize intracytoplasmic sperm injection (ICSI) technology to breed a "test-tube baby" and the birthplace of the first "test-tube baby" in West China adopting preimplantation genetic diagnosis (PGD) technology.

To date, the department has helped birth more than 60,000 "test-tube babies". Its clinical pregnancy rate is stable at over 60 percent and its live birth rate remains higher than 50 percent, which are among the highest rates in the nation. It also ranked seventh among Chinese hospitals in terms of reproductive medicine from 2017 to 2021, according to a list compiled by the Hospital Management Institute of Fudan University.

Technical expertise

The department uses human assisted reproductive medicine clinical technologies including: routine IVF, ICSI, preimplantation genetic diagnosis/screening (PGD/PGS), artificial insemination by donor/husband (AID/AIH), high-throughput gene sequencing carrier screening/prenatal screening/single-gene genetic disease diagnosis, and more.

Experts of Clinical Medicine Department